Chemical industry – Page 104

Business
Does chemical regulation boost innovation?

2013-02-28T00:00:00Z

Report suggests that supply of innovation responds to extra demand created by new laws
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Careers
Toxicologist with pesticides on the brain

2013-02-13T00:00:00Z

Vanessa Fitsanakis’ career in toxicology goes all the way back to the farm where she grew up. Helen Carmichael traces her journey from agriculture to academia
Business
Ozone device for food packaging

2013-02-12T00:00:00Z

Device uses plasma to create ozone inside sealed packaging
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
GSK commits to AllTrials data disclosure

2013-02-07T00:00:00Z

Company will begin publishing all clinical study reports
Business
BASF drops GM potato projects

2013-02-07T00:00:00Z

Move follows transfer of R&D from Europe to US
News
Small business office chemical industry pawn, watchdog claims

2013-02-07T00:00:00Z

The US Small Business Administration’s little-known Office of Advocacy is accused of trying to dilute efforts to regulate certain chemicals
Business
Reach reviewed: no change required

2013-02-06T00:00:00Z

But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
Business
EU proposes neonicotinoid pesticide ban

2013-02-05T00:00:00Z

Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Business
DCD in New Zealand milk

2013-01-31T00:00:00Z

Dicyandiamide poses no food risk but fertiliser companies have suspended sales
Business
Sabic invests $500m in new R&D centres

2013-01-30T00:00:00Z

Four centres to be created: two in Saudi Arabia, one in India and one in China
Business
Unrest over US gas exports

2013-01-30T00:00:00Z

Dow says exports will increase cost of gas and decrease price stability
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
Opinion
Name reactions: how does the label stick?

2013-01-25T00:00:00Z

Derek Lowe investigates the long running tradition of naming reactions after their inventors
Business
Vasella to leave Novartis in August

2013-01-24T00:00:00Z

Long serving chair of the board of directors will be succeeded by Jörg Reinhardt